FDA Drug Application (091158) for ORPHENADRINE CITRATE by INVAGEN PHARMS

Back to FDA Applications sponsored by INVAGEN PHARMS

Application Number091158
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameORPHENADRINE CITRATE
Active IngredientORPHENADRINE CITRATE



Back to FDA Applications sponsored by INVAGEN PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.